Dr. Burton Tabaac, Author at Psychedelics Anonymous

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—SWOT Analysis of Psychedelic Therapeutics

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ketamine

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—Ibogaine

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—N,N-Dimethyltryptamine and Ayahuasca

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—Lysergic Acid Diethylamide (LSD)

Education Legislation Research

Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview

Education Legislation Research

Nevada Lawmakers Hear Dr. Burton Tabaac’s Testimony On Therapeutic Benefits Of Psychedelics

Education

TEDxUCLA: Mental Health Meets Psychedelics by Dr. Burton Tabaac